cached image

William R. Markesbery, MD, University of Kentucky

Affiliations: 
Pathology University of Kentucky, Lexington, KY 
Area:
neurology, oxidative stress, Alzheimer disease
Website:
http://www.research.uky.edu/odyssey/spring10/markesbery.html
Google:
"William Markesbery"
Bio:

http://www.biomedexperts.com/Profile.bme/887009/William_R_Markesbery

http://uknow.uky.edu/node/6828

http://www.legacy.com/obituaries/kentucky/obituary.aspx?n=william-r-markesbery&pid=139242028

http://www.ukalumni.net/s/1052/index-no-right.aspx?sid=1052&gid=1&pgid=874

http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=24

Cross-listing: Neurotree - Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Iacono D, Zandi P, Gross M, et al. (2015) APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study. Oncotarget. 6: 14082-91
Gwon AR, Park JS, Arumugam TV, et al. (2012) Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease. Aging Cell. 11: 559-68
Poon LW, Woodard JL, Stephen Miller L, et al. (2012) Understanding dementia prevalence among centenarians. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 358-65
Ding Q, Zhu H, Zhang B, et al. (2012) Increased 5S rRNA oxidation in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 29: 201-9
Bradley MA, Xiong-Fister S, Markesbery WR, et al. (2012) Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiology of Aging. 33: 1034-44
Gleichmann M, Zhang Y, Wood WH, et al. (2012) Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks. Neurobiology of Aging. 33: 205.e1-18
Robinson RA, Joshi G, Huang Q, et al. (2011) Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease. Proteomics. 11: 4243-56
Sultana R, Robinson RA, Di Domenico F, et al. (2011) Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age. Journal of Proteomics. 74: 2430-40
Aluise CD, Robinson RA, Cai J, et al. (2011) Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. Journal of Alzheimer's Disease : Jad. 23: 257-69
Kramer PL, Xu H, Woltjer RL, et al. (2011) Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiology of Aging. 32: 2113-22
See more...